Company / Depreciation & Amortization
Opus Genetics, Inc. Depreciation & Amortization History
FY2011-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$10.0K
FY2025
5-year range
$4.0K / $10.0K
FY2021-FY2025
Trend
+66.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Increased from $4,000 to $10,000 over the past 2 years.
Based on SEC 10-K filings.
$10,000 in FY2025 with a 3-year CAGR of +35.7%.
Increased from $4,000 to $10,000 over the past 2 years.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- +35.7%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of +35.7%, indicating consistent growth.
- In FY2025, depreciation & amortization increased 66.7% year-over-year.
- Peak depreciation & amortization was recorded in FY2013.
- Lowest depreciation & amortization in the period was in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -2.95 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $10.0K | +66.7% |
| FY2024 | $6.0K | +50.0% |
| FY2023 | $4.0K | +0.0% |
| FY2022 | $4.0K | -50.0% |
| FY2021 | $8.0K | -81.1% |
| FY2013 | $42.4K | +1.9% |
| FY2011 | $41.6K | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026